loading

Xilio Therapeutics Inc (XLO) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
-
- - - -
Operating Expenses
3.55%
17.49
18.13 17.36 20.12 23.53
Operating Income/Loss
3.55%
-17.49
-18.13 -17.36 -20.12 -23.53
Nonoperating Income/Loss
40.21%
0.284
0.475 0.613 0.761 0.88
Income/Loss From Continuing Operations Before Tax
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Income/Loss From Continuing Operations After Tax
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Net Income/Loss
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
135.87K%
27.91
0.0205 27.52 27.47 27.43
Basic Earnings Per Share
3.12%
-0.62
-0.64 -0.61 -0.70 -0.83
Diluted Earnings Per Share
3.12%
-0.62
-0.64 -0.61 -0.70 -0.83
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
大文字化:     |  ボリューム (24 時間):